Exchange: NASDAQ·Updated 07:59 PM EST
CLRB logo

CLRB Cellectar Biosciences Inc

$0.797
$0.0859
(9.73%)
Today
Closed $0.797
$0.007
(0.88%)
After Hours
Reported EarningsNov 10
Mkt Cap$8M
Vol81,068.00

About CLRB

Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded on June 24, 1996 and is headquartered in Florham Park, NJ.
68

Bullish Sentiment

How do you feel about CLRB?

EvenBetter99
$CLRB Cellectar Biosciences' CLOVER WaM results are a clinical triumph! Iopofosine I 131 achieved an extraordinary 87.5% overall response rate, 79.2% major response rate, and 100% clinical benefit in post-BTKi Waldenström patients. With durable 16-month responses and 19.1 months of treatment-free survival, this breakthrough sets up a massive 1H27 FDA accelerated approval filing! 🔥🔥🔥🔥🔥🔥
1
2
MSG8898
$CLRB Nanta&friends will have to dilute the co strongly in order to recoup their money in the medium term, if any. If they dilute at 0.8 their average could be either 1.7 or 1.4 with warrants attached. Either way they would all recoup higher with a company sale.
1
M31V1
$CLRB This one either goes absolutely parabolic to the upside or… I honestly don’t even want to contemplate the alternative.
5
Jloveissoreal
$CLRB Cellectar Biosciences (NASDAQ: CLRB) published a case study describing a complete response lasting more than eight years in a patient with diffuse large B-cell lymphoma (DLBCL) treated with a single administration of iopofosine I 131.
5
M31V1
$CLRB I understand the promotional framing, you’re clearly long, but the lack of any partnership despite the strong results is a major red flag. I’m hoping there’s some kind of pump so we can all exit cleanly.
3
AdamBrennan2
cellectar $CLRB has grown its share count by 207% over the last ten years its a cancer drug developer with no revenue yet, so it has paid for trials by issuing new shares. the page says dilution outpaces buybacks the money went into clinical trial sites and lab equipment for its radioconjugate cancer drugs $REGN $ARGX $NTRA $RVMD
3
focafoca99
$CLRB details a durable 8-year complete response in a DLBCL patient after a single iopofosine I-131 dose.
4
EvenBetter99
$CLRB Anytime likely: An ex-US licensing deal for $CLRB’s iopofosine I-131 looks highly likely. Backed by strong CLOVER WaM data and a strategic EU filing pause over pricing, a regional partnership offers prime non-dilutive cash to extend runway past Q2 2027. 🔥🔥🔥🔥🔥🔥🔥🔥
2
M31V1
$CLRB SABCS LBA closed Sep 30. Titles released Oct 30 include every accepted abstract, none for CLR 125. On the earnings call today, management still said they “remain on track” to present at SABCS. What gives?
1
higgggghhhher
$CLRB continue to strengthen our partnership/buyout. First line coming soon. If I had this disease, I very much would rather have four infusions and be done compared to taking a pill every day that has some serious side effects 
3
EvenBetter99
$CLRB• Broad Pipeline: The tech acts as a vehicle for various payloads (radioisotopes or small molecules).🏆
2
StocktwitsEarnings
$CLRB Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.46 up 67.38% YoY • Cellectar believes its September 30, 2026 cash balance is adequate to fund budgeted operations into the second quarter of 2027; Phase 3 dosing remains on track for Q1 2027, with NDA submission planned in 1H27.
2
PoseidonCalls
Micro float FMFC is getting a lot of attention! Could be the next parabolic premarket runner! They have been sending these low float tickers up for 300%+ runs lately! 💎 FMFC starting to get found now. Would not be shocked to see it squeeze. Only 242k shares outstanding - keep it on watch bulls! $CLRB $GLD *(
1
MSG8898
$CLRB I came up with the gut feeling they might be announcing a global partnership soon, after stretching it long enough to see if they could license it regionally in EU and dropped it at the very end. Just my gut feeling.
1
Aawilliam2003
$CLRB Does anyone here ever spend time on Youtube? Celectar is actually running ads touting their drug on there. Good lord, talk about desperation. Shameless
PoseidonCalls
Short sellers are ruining american small caps and driving companies into bankruptcy!! FMFC has barely 800 watchers on Stocktwits and has been shorted down to only 1.5 million market cap. You could literally buy the ENTIRE company! Webull data stating that FMFC has only 492k shares outstanding and 243k shares float. Watch FMFC here. Making a move 🚀 💎 👀 $CLRB $PRIM Watching
MSG8898
$CLRB they got barely a bit more than a month to pull out a rabbit and partner ipofosine at least in EU (more or less 'till the second week of December). Otherwise this will be heading down big time.
higgggghhhher
$CLRB trial end In may. The clr 131 trial results could maybe be released? You know the whole mechanism thing. Same with the ped program ended in may. Another clr 131 thing…
higgggghhhher
$CLRB let’s start giving valuable info on this board. I’ll start. We are going for first line now. Look at new slides

Advertisement|Remove ads.